Background Reoperation rates are high after surgery for hip fractures. We investigated the effect of a sliding hip screw versus cancellous screws on the risk of reoperation and other key outcomes.
Introduction
Worldwide, 4·5 million people per year become disabled after sustaining a hip fracture, with the number living with disability due to hip fracture expected to increase to 21 million in the next 40 years.
1,2
Despite surgical intervention, the need for reoperation remains high (10·0-48·8%), has remained largely unchanged in the past 30 years, 3, 4 and is associated with substantial morbidity, mortality, and costs. 5 The high proportion of reoperations has generated controversy about the optimum approach for fixing femoral neck fractures. 6 Biomechanical and laboratory studies 7 suggest that although a single large screw at a fixed angle with a sideplate (ie, a sliding hip screw) provides greater biomechanical stability, especially in displaced and unstable fracture types, multiple cancellous screws, which is the present standard of care, are less invasive and better preserve blood supply. Previous small trials 6 did not find a difference in the effect of the two fixation approaches on outcomes important to patients, particularly reoperations, leaving uncertainty among surgeons about the optimum approach for fixing femoral neck fractures.
We did the Fixation using Alternative Implants for the Treatment of Hip fractures (FAITH) trial to examine the effect of a sliding hip screw versus cancellous screws on the risk of reoperation and other key outcomes during 24 months.
Methods

Study design and participants
FAITH was an international, multicentre, allocation concealed, randomised controlled trial assessing the effects of a sliding hip screw versus cancellous screws on reoperation rates over a 24 month follow-up in patients with a low-energy femoral neck fracture. A previous report 8 details the trial objectives and methods. All participating centres obtained ethics approval.
We enrolled patients with a low-energy fracture of the hip requiring fracture fixation across 81 clinical centres in the USA, Canada, Australia, the Netherlands, Norway, Germany, the UK, and India. Eligible patients were those aged 50 years or older with a low-energy femoral neck fracture requiring operative fixation. Complete eligibility criteria are provided in the appendix. All patients provided written informed consent.
Randomisation and masking
Patients were randomly assigned by minimisation to receive a sliding hip screw or cancellous screws, with a centralised computer system to ensure allocation concealment and balanced prognosis between intervention groups for fracture displacement, age, prefracture living status, prefracture function, American Society for Anesthesiologists class, and centre. 9 The study computer programmer generated the minimisation algorithm. Local research personnel at each site performed randomisation by minimisation using the centralised computer system. Surgeons and patients were not masked but the data analyst, while doing the analyses, remained masked to treatment groups.
Procedures
Participants allocated to the sliding hip screw group received a single large-diameter (8·0 mm), partly threaded screw affixed to the proximal femur with a side plate (with a minimum of two holes and a maximum of four holes) and no supplemental fixation. Patients allocated to the cancellous screws group received multiple threaded screws, with a minimum of two screws and diameter of 6·5 mm. All participating surgeons had done at least 25 hip fracture fixation procedures during their career, and at least five fracture fixation procedures in the year before participation.
Surgeons chose the manufacturer, the reduction technique, whether to do a capsulotomy or aspiration of intracapsular haematoma, and the final screw position; injectable bone substitutes were not permitted. The protocol specified perioperative antibiotics, thromboprophylaxis, and weight-bearing regimens, but left to the surgeons' discretion patient positioning, fracture reduction, and surgical exposure in the operating room. We provided surgeons with specific criteria for acceptability of postfixation radiographic fracture alignment.
Participants returned for follow-up at 1 and 10 weeks, and at 6, 9, 12, 18, and 24 months after surgery. Additional details of the trial intervention and standardisation of perioperative care, surgeon expertise, and the follow-up processes are provided in the appendix.
Outcomes
The primary endpoint was reoperation, defined as surgery that occurred subsequent to the initial procedure and within 24 months to promote fracture healing, relieve
Research in context
Evidence before this study We searched the computerised databases Medline and PubMed for randomised clinical trials published in English between Jan 1, 1969, and June 1, 2002, using the search terms "femoral neck fracture" AND "arthroplasty", as well as "femoral neck fracture" AND "internal fixation". In addition, bibliographies were searched for relevant studies. We also identified additional studies through hand searches of major orthopaedic journals, bibliographies of major orthopaedic textbooks, and personal files. Of 140 citations initially identified, 14 met all eligibility criteria. Three investigators independently graded study quality and abstracted relevant data, including information on revision and mortality rates. An international survey of orthopaedic surgeons identified that most surgeons preferred to fix femoral neck hip fractures with multiple cancellous screws rather than a sliding hip screw. Despite the popularity of cancellous screws for hip fracture fixation, biological investigations have suggested that the sliding hip screw is a more biomechanically stable construct compared with cancellous screws. Moreover, a previous Cochrane meta-analysis of small trials reported a non-significant reduction in reoperations with a sliding hip screw compared with multiple cancellous screws (relative risk 0·86, 95% CI 0·70-1·05), and that the risk of avascular necrosis with a sliding hip screw was significantly reduced. The small sample sizes and resultant imprecise estimates, and methodological limitations, of previous work left the issue in doubt.
Added value of this study Our trial enrolled more than 1000 patients across multiple countries, providing improved precision and generalisability to both high-income countries and low-to-middle-income countries. Our trial also addresses the dearth of health-related quality-of-life data for patients who had surgical fixation for femoral neck fractures.
Implications of all the available evidence Although our findings, consistent with those of previous randomised controlled trials, did not show a difference in the likelihood of reoperation in patients randomly assigned to a sliding hip screw versus cancellous screws, health-related quality of life was similar across both interventions. However, we did show a significant increase in the likelihood of avascular necrosis with a sliding hip screw compared with cancellous screws. Nonetheless, this finding is not only inconsistent with previous results, but also did not result in an overall increase in reoperations or a decrement in health-related quality of life. Moreover, our results raise the possibility that a sliding hip screw, relative to cancellous screws, might reduce reoperations in patients with displaced fractures, in smokers, and in patients with base of neck fractures.
pain, treat infection, or improve function. An independent Central Adjudication Committee, adjudicated all primary and key secondary outcomes (mortality, fracture healing, and fracture complications, including avascular necrosis, non-union, implant failure, and infections). Healthrelated quality of life was measured by the Short Form-12, the EuroQol-5 Dimensions, and the Western Ontario and McMaster Universities Arthritis Index. Details of the primary outcomes, secondary outcomes, and adjudication processes are provided in the appendix.
All adverse events were reported to local ethics boards as per local requirements. An independent Data and Safety Monitoring Board monitored the safety of the trial and reviewed all serious adverse events.
Statistical analysis
The sample size calculation was based on the primary outcome of hip reoperation and used the Cox proportional hazards model as described by Collett. 10 Originally we determined that enrolment of 1500 patients would give the trial 81·5% power to detect a hazard ratio (HR) of 0·75 in the sliding hip screw group, at a two-sided alpha level of 0·05, on the assumption that the percentage of the primary outcome in the cancellous screws group would be 25% (appendix).
8
The Data and Safety Monitoring Board met in January, 2014, after 589 patients completed follow-up. They provided the Steering Committee with overall event rates to inform a revised power analysis that balanced feasibility of completing recruitment within an acceptable timeframe and supporting plausible hypotheses of treatment effect and baseline event rates. On the basis of the number of events in the first 589 patients, we estimated a 24 month primary event rate of 27·2%; a 24 month mortality rate of 18·2%; a 24 month 5·9% incidence of loss to follow-up; and a combined 6·8% crossover rate. With these estimates, a sample size of 500 patients per group would provide 95·7% power to detect a relative risk reduction of 35%. On the basis of these data, we targeted a sample size of 1100 patients. A methods paper 8 published previously presents details of the sample size calculations and rationale.
Analyses followed the intention-to-treat principle and included all patients in the groups to which they were randomly assigned. Patients who did not complete the 24 month follow-up were censored at their last documented follow-up. After assessment of its appropriateness, the primary analysis used a Cox proportional hazards model stratified by clinical site. We report the treatment effects as HRs and 95% CIs. An analysis adjusting for death as a competing risk provided a sensitivity analysis. The analyses of treatment effect on fracture-related adverse events and mortality also relied on a stratified Cox proportional hazards regression.
We analysed the health-related quality-of-life outcomes at 24 months using a multiple linear regression model with treatment and pre-injury quality of life (obtained at 1 week) included as independent variables. Results are reported as mean differences with corresponding 95% CIs and p values.
At the trial onset we specified a single a-priori subgroup analysis investigating fracture displacement as a possible effect modifier, anticipating that sliding hip screw relative to multiple cancellous screws would do better in displaced versus non-displaced fractures.
10 At the completion of the trial, but before unblinding and as described in our statistical analysis plan, we prespecified an additional five subgroup analyses that investigated a possible effect modification by location of fracture line, body-mass index, verticality of the fracture line, smoking status, and quality of fracture reduction. We did an additional post-hoc subgroup analysis assessing the possible effect Details for postulated subgroup effects are provided in the appendix. All analyses were done with SAS version 9.4 (Cary, NC, USA). This study was registered with ClinicalTrials.gov, number NCT00761813.
Role of the funding source
The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication. Data are mean (SD) or n/N (%). For some subgroups, the numbers of patients analysed are smaller than that of the overall group number because data are missing for some variables. NSAIDS=non-steroidal anti-inflammatory drugs. BMI=body-mass index. figure 1, appendix). The mean length of follow-up was 633 days (SD 208). Typical patients were women aged 70-80 years who had fallen and sustained an isolated, non-displaced fracture of the femoral neck; group characteristics were similar (tables 1, 2). Acceptable reduction (open and closed) was achieved in nearly all patients (99%; table 2). In 549 patients with displaced fractures, acceptable reduction was achieved in 545 (99%). Those who underwent cancellous screw fixation typically received three parallel screws in a triangular configuration, whereas those in the sliding hip screw group received a single large compression screw in the centre-centre head position with a two-hole side plate; perioperative management was similar across groups (tables 1, 2; appendix).
Results
Between
The overall crossover was 2·0%, with significant differential crossovers between treatment groups (p=0·03). Surgeon compliance for the initial allocated surgical fixation approach was 97% (n=16) for sliding hip screw and 99% (n=6) for cancellous screws (appendix).
The primary study endpoint, hip reoperation within 24 months, did not differ by type of surgical fixation (table 3, figure 2). A competing risk sensitivity analysis adjusting for death yielded similar results for the primary endpoint (0·89, 0·69-1·16).
Number of deaths did not differ between groups (table 3) . Avascular necrosis occurred in about 7% of patients overall and differed by fixation group, with more occurring in the sliding hip screw group than in the cancellous screws group. Of these, 54 (69%) patients required an operation: 38 patients in the sliding hip screw group and 16 in the cancellous screws group (p=0·002). Implant removal took place significantly less frequently in the sliding hip screw group than in the cancellous screws group (table 3) . Implant exchange to revise to another internal fixation also occurred less frequently with sliding hip screws than cancellous screws (table 3) . Alternatively, implant exchange to a total hip replacement was more common in the sliding hip group.
Non-unions, implant failures, infections, fracture shortening, and fracture healing did not differ by surgical fixation approach (table 3) . Health-related quality of life did not differ between patients assigned to sliding hip screws and multiple cancellous screws at 12 month and 24 month follow-up (table 4) .
Medically related adverse events did not differ by treatment group (p=0·82; table 5).
Subgroup analyses favoured sliding hip screw in patients with displaced fractures, fractures at the base of the femoral neck, and in those who were current smokers (appendix, figure 3). Only smoking status remained significant when these three subgroups were entered into a single analysis (figure 3). Sliding hip screw was superior in current smokers, but not in former or nonsmokers (figure 3, appendix). Data are n (%). Relative risk was calculated where the total number of events is less than 50. *795 patients were included in the fracture healing analysis. 284 patients did not have radiograph available for fracture healing adjudication, and therefore were not included in the denominator. †532 patients were included in the shortening analysis on the basis of the number of healed fractures with shortening data. 
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Discussion
We have shown a similar risk of hip reoperation in patients with low-energy femoral neck fractures randomly assigned to sliding hip screw as in those assigned to cancellous screws at 24 months; avascular necrosis occurred more frequently in patients allocated to sliding hip screw. Subgroup analyses of low-to-moderate credibility, suggested sliding hip screws reduced reoperations in patients with displaced fractures, fractures at the base of the femoral neck, and in current smokers. Although the frequency of reoperations was similar between the two treatment groups, there were differences in the component outcomes of reoperations. Patients in the sliding hip screw group, compared with those in the cancellous screws group, had a lower frequency of a reoperation for an implant removal and an implant exchange based on an internal fixation approach, but had a higher frequency of reoperation for an implant exchange with a total hip arthroplasty approach. Patients undergoing total hip arthroplasty after failed internal fixation compared with those undergoing primary total hip arthroplasty could be at higher risk of complications. 19 As such, the number of arthroplasties in the cancellous screws group suggests a potential advantage of the treatment over a sliding hip screw. Although the decision to choose one approach to implant exchange over another was left to the surgeon's discretion, the choice might also indicate surgeon preference.
Looking separately at possible effect modifiers, displaced versus non-displaced fractures, fracture site, and smoking status, interaction p values all reached conventional statistical significance, all suggesting benefits of sliding hip screws over cancellous screws in a subpopulation of patients (figure 3). All were a-priori hypotheses with a biological rationale that led to a correct predicted direction of effect. In particular, the greater biomechanical stability of sliding hip screws might offer advantages in fracture with displacement and in smokers, who have greater risk of osteoporosis and diminished bone density than do non-smokers.
7,20-23 Sliding hip screws remain the standard of care in patients with intertrochanteric fractures, a region in close proximity to the base of the femoral neck, 24 providing a biological rationale for the finding that sliding hip screws reduced reoperations in the subgroup of patients with base of femoral neck fractures. Furthermore, the displacement hypothesis was originally our sole hypothesis and a minimisation variable.
11,12
However, when all three potential effect modifiers were considered together, only smoking retained a low, although not extremely low, p value ( figure 3 ). Additionally, we tested multiple hypotheses, and did not find similar effects in health-related quality of life. As such, in view of all these issues, the apparent subgroup effects have only modest credibility.
Strengths of FAITH include safeguards against risk of bias (concealed randomisation, centralised and independent outcome adjudication, blinded analysis of data); high compliance with study procedures; broad inclusion criteria with a large number of centres in countries with diverse health-care systems; a focus on outcomes of importance to both patients and the health-care system (ie, reoperation, health-related quality of life); and rigorous investigation of subgroup effects, with due attention to their credibility.
Our study has limitations. Surgeons and patients were not blinded. However, we did minimise the associated risk of bias with central and independent, although unblinded, radiographic adjudication of the primary endpoint. Furthermore, reoperation is an objective endpoint and a major procedure; surgeons will seldom decide to reoperate 3 Unavoidable heterogeneity related to the variables that were not standardised also existed; these variables were patient positioning, fracture reduction, surgical exposure, use of operative traction, surgical delay, type of anaesthetic, physiotherapy, and rehabilitation programmes.
In relation to previous research, a meta-analysis of small trials suggested a non-significant difference in reoperations favouring sliding hip screw (relative risk 0·86, 95% CI 0·70-1·05; p=0·13). 19 An updated pooled analysis of reoperation including small trials with our FAITH results (eight trials, 1913 patients) reported a 95% CI that was narrower than our study's but was still consistent, with no difference between fixation methods (0·91, 0·76-1·08; p=0·27, I²=7%). [25] [26] [27] [28] [29] [30] [31] With respect to avascular necrosis, our results differ importantly from a previous systematic review 19 of small trials, which suggested that a sliding hip screw, in comparison with cancellous screws, might reduce the risk of avascular necrosis. The addition of another small trial to a previous meta-analysis results in a significant reduction in the risk of avascular necrosis with sliding hip screws (77 events; relative risk 0·64, 95% CI 0·43-0·97; p=0·04, I²=0%).
19,25
Despite the previous results, increased risk of avascular necrosis from our results has a plausible biological rationale. Hip fractures can disrupt the retinacular vessels, which are crucial for the vascular supply of the femoral head. 32 A randomised trial 33 of 104 patients with femoral neck fractures using bone scintigraphy showed reduced vascularity in patients receiving a sliding hip screw compared with those receiving cancellous screws (35% vs 11%, p<0·01). Furthermore, suboptimum positioning of large implants, such as sliding hip screws, risks damage to the blood supply to the femoral head. 34 In terms of the importance of avascular necrosis, observational studies have shown that many patients remain asymptomatic, with only one in five requiring further surgery. 35, 36 Our results, in the context of previous results, suggest that the choice of procedure for internal fixation is a matter of discretion. Findings favouring cancellous screws were the non-significant difference in the likelihood of reoperation between procedures, and the higher likelihood of avascular necrosis and subsequent total arthroplasties in patients receiving a sliding hip screw. However, our finding of increased avascular necrosis with a sliding hip screw, compared with cancellous screws, is inconsistent with other studies and did not result in more operations or poorer quality of life in the total population. Moreover, findings across all trials remain consistent, with overall decreased reoperations in 
Favours cancellous screws Favours sliding hip screw patients receiving a sliding hip screw, and subgroup analyses of low credibility suggesting that patients with displaced fractures, smokers, and patients with base of neck fractures might do better with a sliding screw than with cancellous screws.
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Eligibility Criteria
Inclusion Criteria 1) Adult men or women aged 50 years and older (with no upper age limit).
2) Fracture of the femoral neck confirmed with either anteroposterior and lateral hip radiographs, computed tomography, or magnetic resonance imaging (MRI).
3) Operative treatment of displaced fractures within four days of presenting to the emergency room.
4)
Operative treatment of undisplaced fractures within seven days of presenting to the emergency room.
5)
Patient was ambulatory prior to fracture, though they may have used an aid such as a cane or a walker.
6) Anticipated medical optimization for operative fixation of the hip.
7)
Provision of informed consent by patient or legal guardian.
8)
No other major trauma (defined as an Injury Severity Score >16*). 9) Low energy fracture, in the judgment of the attending surgeon.
Exclusion Criteria
1)
Patients not suitable for internal fixation (i.e., severe osteoarthritis, rheumatoid arthritis, or pathologic fracture).
2) Associated major injuries of the lower extremity (i.e., ipsilateral or contralateral fractures of the foot, ankle, tibia, fibula, knee, or femur; dislocations of the ankle, knee, or hip; or femoral head defects or fracture).
3) Retained hardware around the affected hip.
4)
Infection around the hip (i.e., soft tissue or bone).
5)
Patients with disorders of known bone metabolism except osteoporosis (i.e., Paget's disease, renal osteodystrophy, osteomalacia). 6) Patients with a history of frank dementia that would interfere with assessment of the primary outcome (i.e., reoperation at two years). 7) Likely problems, in the judgment of the investigators, with maintaining follow-up (i.e., patients with no fixed address, report a plan to move out of town, or intellectually challenged patients without adequate family support).
Trial Interventions and Standardization of Peri-Operative Care
A.
Multiple Cancellous Screws
Surgeons were allowed to use any threaded screw or hook pin (i.e., Gouffon, Uppsala, von Bahr, Hansson hook pins, etc.) or cancellous threaded screw (i.e., cannulated or non-cannulated, Depuy-ACE screws, AO/Association for the Study of Internal Fixation (ASIF), Asnis, Richards, etc.). Surgeons followed the technique guides associated with the screw manufacturers.
Any combination of procedures (cancellous screws and/or sliding hip screws) performed by surgeons were accepted as expertise. Additionally, any combination of these procedures performed for any type of hip fracture (i.e., femoral neck fracture, intertrochanteric fracture, etc.) were accepted as expertise. The Adjudication Committee reviewed fracture complications including avascular necrosis, nonunion, implant failure, and infections. Mortality Mortality was adjudicated and it was considered to be an event if it occurred within 24 month of the fracture.
Follow-up Processes
Fracture Healing and Shortening
The Adjudication Committee reviewed all available x-rays for fracture healing. The health-related quality of life outcomes being analyzed included:  SF-12 Physical Component Score, which measures self-reported quality of life through physical summary measures and a preference-based health utility index  EQ-5D, which is a standardized instrument for use as a measure of health outcome  WOMAC, which is self-administered and assesses the three dimensions of pain, disability and joint stiffness in knee and hip osteoarthritis
Overview of Adjudication Adjudication Processes
The following information was excerpted from the FAITH Adjudication Charter, which documents the responsibilities of the Adjudication Committee and the adjudication processes for the FAITH trial.
1) Fracture Eligibility
The Adjudication Committee adjudicated fracture eligibility in cases where eligibility was in doubt based on available pre-surgery and post-surgery x-rays, and completed case report forms. Fracture eligibility was not affected by the implant used, even in situations where the patient did not receive cancellous screws or a sliding hip screw (a protocol deviation).
2) Radiographic Characteristics and Quality of Surgery
The Adjudication Committee classified the level of the femoral neck fracture as subcapital, midcervical or basal, determined the type of fracture and classified it as being undisplaced (Garden I or II) or displaced (Garden III or IV), and classified the fracture using the Pauwels' classification. The Committee determined if the quality of the reduction and the quality of implant placement were acceptable or unacceptable.
3) Fracture Healing
The Adjudication Committee began assessment of a patient's fracture healing after the patient's 24-month followup. They adjudicated all available radiographic visits at and after the week 10 time point. Along with fracture healing, the Committee assessed the amount of fracture shortening as follows: no shortening, mild shortening (≤ 5 mm), moderate shortening (6-10mm), or severe shortening (>10mm).
4) Re-operations
The Adjudication Committee adjudicated re-operations after each patient had completed their 24-month follow-up (or following early withdrawal). Specifically, the Committee adjudicated all re-operations to promote fracture healing, relieve pain, treat infection, or improve function. The Committee reviewed all available x-rays, and data from the patient's completed case report forms. Planned re-operations were not considered events.
5) Fracture-Related Complications
The Adjudication Committee adjudicated fracture-related complications after each patient had completed their 24-month follow-up (or following early withdrawal). The Committee reviewed all available x-rays, and data from the patient's completed case report forms.
6) Mortality
The Adjudication Committee adjudicated mortality as required following a patient's early withdrawal. The Committee reviewed all data from the patient's completed case report forms. Relative risk was calculated where the total number of events is less than 50 *571 patients were included in the fracture healing analysis. 284 patients did not have x-rays available for fracture healing adjudication, and therefore were not included in the denominator. **418 patients were included in the shortening analysis based on the number of healed fractures with shortening data.
Sample Size Calculations (FAITH
Page 18 of 21 Relative risk was calculated where the total number of events is less than 50 *224 patients were included in the fracture healing analysis. 284 patients did not have x-rays available for fracture healing adjudication, and therefore were not included in the denominator. **114 patients were included in the shortening analysis based on the number of healed fractures with shortening data.
Page 20 of 21 EQ-5D Index 0·80 (0·19), 76 0·79 (0·20), 68 0·02 (-0·04, 0·07), N=137 0·59
